Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of Immunological Methods|May 2, 2002
Evaluation of IFNalpha bioavailability by MxA mRNA in HCV patientsF Gilli, A Sala, C Bancone, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 8, 2006
Biological markers of interferon-beta therapy: comparison among interferon-stimulated genes MxA, TRAIL and XAF-1F Gilli, F Marnetto, M Caldano, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 3, 2006
Fate of multiple sclerosis patients positive for neutralising antibodies towards interferon beta shifted to alternative treatmentsS Malucchi, M Capobianco, F Gilli, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 18, 2004
Biological activity of interferon betas in patients with multiple sclerosis is affected by treatment regimen and neutralising antibodiesA Bertolotto, A Sala, S Malucchi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 6, 2003
Neuromyelitis optica: importance of cerebrospinal fluid examination during relapseE Milano, A Di Sapio, S Malucchi, et al.
Journal of Neuroimmunology|December 14, 2004
Biological responsiveness to first injections of interferon-beta in patients with multiple sclerosisF Gilli, F Marnetto, M Caldano, et al.
Pageof 2